2m 2m 2m 2m 2m 2m 2m
CORB PHRM HLDGS (CRBP)
NASDAQ
$4.04+$0.04 (+0.97%)
Price as of Nov 12, 2026 7:53 AM EST- $77.4MMarket Cap
- -64.25%1-Year Change
- BiotechnologyIndustry
CORB PHRM HLDGS (CRBP)
$4.04+$0.04 (+0.97%)
CRBP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.00 | ||
Change | +$0.07 (+1.78%) | ||
Open | $4.04 | ||
High | $4.20 | ||
Low | $3.80 | ||
Previous Close | $3.93 | ||
Volume | 672,732 | ||
30-Day Average Volume | 1,136,617 | ||
1-Week Change | 12.04% | ||
1-Month Change | -25.65% | ||
1-Year Change | -64.25% | ||
3-Year Change | 23.08% | ||
5-Year Change | -87.30% | ||
Fundamentals | |||
Shares Outstanding | 19.3M | ||
Total Assets | $122.9M | ||
Market Cap | $77.4M | ||
Enterprise Value | $47.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$37.8M | ||
Free Cash Flow | -$21.3M | ||
EBIT | -$37.8M | ||
EBITDA | -$37.7M | ||
Net Working Capital | $84.0M | ||
EPS | -$1.81 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | N/A | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 02/14/2023 | ||
Earnings & Revenue